rs267607844
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000249.4(MLH1):c.1668-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MLH1
NM_000249.4 splice_region, intron
NM_000249.4 splice_region, intron
Scores
2
Splicing: ADA: 0.9995
2
Clinical Significance
Conservation
PhyloP100: 3.30
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-37042265-C-A is Pathogenic according to our data. Variant chr3-37042265-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 89829.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr3-37042265-C-A is described in Lovd as [Likely_pathogenic]. Variant chr3-37042265-C-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLH1 | NM_000249.4 | c.1668-3C>A | splice_region_variant, intron_variant | ENST00000231790.8 | NP_000240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH1 | ENST00000231790.8 | c.1668-3C>A | splice_region_variant, intron_variant | 1 | NM_000249.4 | ENSP00000231790.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000237 AC: 34AN: 1437474Hom.: 0 Cov.: 29 AF XY: 0.0000265 AC XY: 19AN XY: 716444
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
34
AN:
1437474
Hom.:
Cov.:
29
AF XY:
AC XY:
19
AN XY:
716444
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1Uncertain:2
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Lynch syndrome Pathogenic:1
Likely pathogenic, reviewed by expert panel | curation | International Society for Gastrointestinal Hereditary Tumours (InSiGHT) | Oct 18, 2018 | Exon 15 skipping shown in minigene & RT-PCR & possibly 2 MSI tumours (1 from Dieumegard et al 2000 & 1 from UMD) - |
Carcinoma of colon Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The c.1668-3C>A variant has been reported in the literature in 1/68 proband chromosomes of an individual with incomplete HNPCC. This patient showed a strong family history of CRC, but was missing at least one HNPCC criterion. The variant was not found in any of the 192 control chromosomes tested. The tumor from this patient was MSI positive, lacked IHC MLH1 staining, and was found to exhibit LOH (Dieumegard_2000_10732761). The variant is located in the 3' splice region but does not affect the invariant -1 and -2 positions. However, positions -3 and -5 to -12 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing, increasing the likelihood that this variant has clinical significance Computational prediction software (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predicts a greater than 10% difference in splicing in 2 of 5 different programs. However, this information is not predictive enough to rule out pathogenicity. In summary, based on above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a Variant of Unknown Significance. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.1668-3C>A intronic variant results from a C to A substitution 3 nucleotides upstream from coding exon 15 in the MLH1 gene. This variant has been reported in a female diagnosed with endometrial cancer at age 48, rectal cancer at age 56, and three colon cancers at ages 63, 65, and 67. One colon tumor was MSI-H and exhibited loss of MLH1 on immunohistochemistry. Family history consisted of colorectal cancer in two relatives, endometrial cancer, and breast cancer (Dieumegard B et al. Br. J. Cancer, 2000 Feb;82:871-80). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 3
Find out detailed SpliceAI scores and Pangolin per-transcript scores at